Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00141115 · ClinicalTrials.gov registry record · Phase 2
Levetiracetam for the Treatment of Alcohol Dependence and Anxiety
A Phase 2 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT00141115 is a Phase 2 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 3 participants.
The verdict
NCT00141115, a Phase 2 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if levetiracetam is effective in treating alcohol dependence in patients with anxiety symptoms. The researchers hypothesize that individuals are unable to reduce or discontinue alcohol use because of significant anxiety, mood, and sleep disturbance symptoms that accompany reduction in alcohol use.
Interventions
- DRUG levetiracetam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2004-03 |
| Est. Completion | 2008-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00141115
The ClinicalTrials.gov registry entry for NCT00141115 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which levetiracetam is the first listed.
NCT00141115 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00141115 about?
NCT00141115 is a clinical study titled "Levetiracetam for the Treatment of Alcohol Dependence and Anxiety". The purpose of this study is to determine if levetiracetam is effective in treating alcohol dependence in patients with anxiety symptoms. The researchers hypothesize that individuals are unable to reduce or discontinue alcohol use because of significant anxiety, mood, and sleep disturbance symptoms ...
What is the current status of trial NCT00141115?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2004-03. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00141115?
The interventions under investigation include: levetiracetam (DRUG).
Who is sponsoring clinical trial NCT00141115?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.